BAL Pharma Limited
Indian Pharmaceutical Exporter ยท Advanced Diabetes Medications Specialist ยท $5.4M Total Trade ยท DGFT Verified
BAL Pharma Limited is an Indian pharmaceutical exporter with a total trade value of $5.4M across 3 products in 3 therapeutic categories. Based on 219 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Gliclazide ($2.6M), Diclofenac ($2.3M), Griseofulvin ($634.0K).
BAL Pharma Limited โ Export Portfolio & Destination Treemap

Who is BAL Pharma Limited? โ Company Overview & Market Position
Bal Pharma Limited, established in 1987, is a prominent Indian pharmaceutical company headquartered in Bengaluru, Karnataka. The company specializes in the manufacturing and marketing of pharmaceutical formulations and active pharmaceutical ingredients (APIs), offering a diverse portfolio that includes prescription drugs, generics, over-the-counter (OTC) products, intravenous infusions, and bulk drugs.
As of March 2025, Bal Pharma reported a workforce of 715 employees. The company is publicly listed on the Bombay Stock Exchange under the ticker symbol 524824 and on the National Stock Exchange of India as BALPHARMA. In the fiscal year ending March 2025, Bal Pharma reported a revenue of approximately โน2,348.39 million.